HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giampaolo Tortora Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

12/2023Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes.
11/2023Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.
2/2023Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies.
1/2023CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer.
12/2022Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
1/2021Endoscopic ultrasound-guided therapies for pancreatic solid tumors: An overview.
1/2021Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study).
1/2021Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer.
1/2019Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
8/2018An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giampaolo Tortora Research Topics

Disease

171Neoplasms (Cancer)
03/2024 - 02/2002
43Renal Cell Carcinoma (Grawitz Tumor)
03/2024 - 10/2012
39Breast Neoplasms (Breast Cancer)
02/2023 - 03/2002
32Prostatic Neoplasms (Prostate Cancer)
02/2024 - 11/2002
28Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 08/2003
23Neoplasm Metastasis (Metastasis)
03/2024 - 07/2003
23Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 12/2006
21Adenocarcinoma
10/2023 - 03/2013
20Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 11/2007
20Lung Neoplasms (Lung Cancer)
11/2023 - 08/2004
20Carcinoma (Carcinomatosis)
02/2023 - 12/2002
14Disease Progression
03/2024 - 11/2002
11Melanoma (Melanoma, Malignant)
01/2023 - 01/2015
9Colonic Neoplasms (Colon Cancer)
02/2010 - 10/2002
8Stomach Neoplasms (Stomach Cancer)
10/2023 - 06/2003
8Urinary Bladder Neoplasms (Bladder Cancer)
02/2022 - 01/2015
8Carcinogenesis
01/2022 - 08/2003
7Triple Negative Breast Neoplasms
02/2024 - 01/2015
7Neutropenia
02/2023 - 08/2014
7Adenocarcinoma of Lung
05/2015 - 02/2005
6Kidney Neoplasms (Kidney Cancer)
03/2024 - 07/2013
4Inflammation (Inflammations)
11/2023 - 01/2014
4Cholangiocarcinoma
08/2023 - 12/2013
4Necrosis
08/2023 - 08/2004
4Febrile Neutropenia
02/2023 - 08/2014
4Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2017 - 01/2015
3Hepatocellular Carcinoma (Hepatoma)
08/2023 - 10/2012
3Fatigue
02/2023 - 01/2015
3Uveal melanoma
01/2023 - 07/2019
3Cardiotoxicity
01/2019 - 08/2014

Drug/Important Bio-Agent (IBA)

49ErbB Receptors (EGF Receptor)IBA
01/2024 - 06/2002
34Biomarkers (Surrogate Marker)IBA
06/2023 - 07/2006
29Immune Checkpoint InhibitorsIBA
03/2024 - 01/2015
25Tyrosine Kinase InhibitorsIBA
03/2024 - 03/2002
22Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2020 - 04/2003
18Hormones (Hormone)IBA
03/2024 - 03/2002
18Gefitinib (Iressa)FDA Link
05/2015 - 03/2002
16Cetuximab (Erbitux)FDA Link
02/2022 - 12/2003
16Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2004
15GemcitabineFDA Link
12/2023 - 12/2006
15DNA (Deoxyribonucleic Acid)IBA
08/2023 - 04/2003
15Monoclonal AntibodiesIBA
02/2022 - 06/2003
11PlatinumIBA
12/2023 - 01/2016
10Docetaxel (Taxotere)FDA Link
01/2022 - 12/2004
10vandetanib (ZD6474)IBA
02/2011 - 12/2002
9130-nm albumin-bound paclitaxelIBA
11/2023 - 02/2015
9Phosphotransferases (Kinase)IBA
04/2022 - 08/2005
9Bevacizumab (Avastin)FDA Link
01/2022 - 07/2007
8cabozantinibIBA
10/2022 - 01/2016
8Growth Factor ReceptorsIBA
12/2021 - 06/2002
8Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2017 - 12/2002
7Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2024 - 01/2004
7Paclitaxel (Taxol)FDA LinkGeneric
02/2024 - 04/2003
7enzalutamideIBA
01/2018 - 07/2013
7Epidermal Growth Factor (EGF)IBA
09/2016 - 10/2002
6NivolumabIBA
10/2022 - 01/2015
6LigandsIBA
01/2022 - 03/2004
6Sunitinib (Sutent)FDA Link
11/2021 - 01/2015
6EverolimusFDA Link
12/2020 - 01/2015
6Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2020 - 04/2003
6OligonucleotidesIBA
08/2014 - 04/2003
5AndrogensIBA
03/2024 - 11/2002
5Leucovorin (Folinic Acid)FDA Link
01/2022 - 11/2007
5Androgen Receptors (Androgen Receptor)IBA
01/2022 - 01/2015
5Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 11/2007
5Toll-Like Receptor 9IBA
08/2014 - 01/2006
4Anaplastic Lymphoma KinaseIBA
03/2024 - 04/2013
4atezolizumabIBA
09/2023 - 01/2015
4palbociclibIBA
02/2023 - 01/2020
4Phenobarbital (Luminal)FDA Link
01/2023 - 10/2016
4pembrolizumabIBA
06/2021 - 01/2015
4CrizotinibIBA
11/2020 - 04/2013
4TensinsIBA
11/2019 - 08/2019
4Trastuzumab (Herceptin)FDA Link
12/2016 - 06/2003
4EnzymesIBA
04/2016 - 12/2005
4Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2012 - 03/2004
3trifluridine tipiracil drug combinationIBA
04/2024 - 01/2023
3Axitinib (AG 013736)IBA
03/2024 - 11/2015
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2023 - 01/2019
3RNA (Ribonucleic Acid)IBA
12/2022 - 04/2003
3human ERBB2 proteinIBA
11/2022 - 09/2013
3AntibodiesIBA
11/2021 - 01/2015
3MicroRNAs (MicroRNA)IBA
08/2021 - 01/2018
3Sorafenib (BAY 43-9006)FDA Link
08/2021 - 10/2012
3Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2021 - 02/2006
3RamucirumabIBA
01/2020 - 11/2017
3Panitumumab (Vectibix)FDA Link
11/2019 - 01/2007
3Heat-Shock Proteins (Heat-Shock Protein)IBA
10/2019 - 01/2015
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2019 - 08/2019

Therapy/Procedure

135Therapeutics
03/2024 - 02/2002
46Drug Therapy (Chemotherapy)
02/2024 - 08/2003
34Immunotherapy
12/2023 - 01/2015
20Castration
01/2022 - 07/2013
16Neoadjuvant Therapy
10/2023 - 08/2014
13Radiotherapy
01/2023 - 10/2002
11Precision Medicine
02/2024 - 01/2015
5Combination Drug Therapy (Combination Chemotherapy)
02/2022 - 01/2013
5Aftercare (After-Treatment)
01/2018 - 02/2003
4Nutritional Support (Artificial Feeding)
02/2023 - 01/2018
3Gastrectomy
03/2021 - 01/2014